IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.
This vulnerability carries a MEDIUM severity rating with a CVSS v3.1 score of 5.3, indicating it requires adjacent network access but requires specific conditions to be met without requiring user interaction and does not require pre-existing privileges . The vulnerability impacts confidentiality (data exposure), for affected systems. Impacting 36 products from philips, from philips, from philips and 33 others, organizations running these solutions should prioritize assessment and patching.
First disclosed in 2018, this vulnerability was reported during a period defined by widespread IoT adoption challenges, mobile security concerns, and the emergence of advanced persistent threat (APT) techniques. Contemporary mitigation strategies focused on secure development practices and third-party component vetting.
2018-06-05T20:29:00.873
2024-11-21T03:41:38.247
Modified
CVSSv3.0: 5.3 (MEDIUM)
AV:A/AC:M/Au:N/C:P/I:N/A:N
5.5
2.9
SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For philips's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.